Xenikos

Xenikos

Developing a novel therapy that aims to reset the immune system of patients suffering from serious immune diseases or rejection after transplantation. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€120—180m (Dealroom.co estimates May 2018.)
Company register number 09206362
Nijmegen Gelderland (HQ)
Authorizing premium user...